advertisement

---

Toris CB 21

Showing records 1 to 21 | Display all abstracts from Toris CB

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Coleman RA
British Journal of Pharmacology 2019; 176: 687-698

---

80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adults
Fan S
British Journal of Ophthalmology 2019; 103: 1845-1849

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodward DF; Wang JW
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adults
Guo T
British Journal of Ophthalmology 2019; 103: 1845-1849

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Woodrooffe AJ
British Journal of Pharmacology 2019; 176: 687-698

---

80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adults
Chen B
British Journal of Ophthalmology 2019; 103: 1845-1849

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Clark KL
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Coleman RA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adults
Xiong J
British Journal of Ophthalmology 2019; 103: 1845-1849

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Toris CB
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodrooffe AJ
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Fan S
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Clark KL
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adults
Havens S
British Journal of Ophthalmology 2019; 103: 1845-1849

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Stamer WD
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Wang JW
British Journal of Pharmacology 2019; 176: 687-698

---

80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adults
Gulati V
British Journal of Ophthalmology 2019; 103: 1845-1849

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Tao G
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Woodward DF
British Journal of Pharmacology 2019; 176: 687-698

---

80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adults
Toris CB
British Journal of Ophthalmology 2019; 103: 1845-1849

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Fan S; Toris CB
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---